Tumor models in cancer research

por Teicher, Beverly A.
Publicado em c201

Cancer drug resistance

por Teicher, Beverly A.
Publicado em c200

Perspective: Opportunities in recalcitrant, rare and neglected tumors

por TEICHER, BEVERLY A.
Publicado em 2013

CD248: A therapeutic target in cancer and fibrotic diseases

por Teicher, Beverly A.
Publicado no Oncotarget (2019)

TGFβ–Directed Therapeutics: 2020

por Teicher, Beverly A.
Publicado no Pharmacol Ther (2020)

Stem cells and cancer

por Bagley, Rebecca G., Teicher, Beverly A.
Publicado em 2009

Antiangiogenic agents in cancer therapy

por Teicher, Beverly A., Ellis, Lee M.
Publicado em 2008

CCR 20(th) Anniversary Commentary: In the Beginning, There Was PS-341

por Teicher, Beverly A., Anderson, Kenneth C.
Publicado no Clin Cancer Res (2015)

Antibody–drug conjugates for cancer therapy

por Thomas, Anish, Teicher, Beverly A, Hassan, Raffit
Publicado no Lancet Oncol (2016)

Are neuroendocrine negative small cell lung cancer and large cell neuroendocrine carcinoma with WT RB1 two faces of the same entity?

por Sonkin, Dmitriy, Thomas, Anish, Teicher, Beverly A
Publicado no Lung Cancer Manag (2019)

Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors

por Issaq, Sameer H, Teicher, Beverly A, Monks, Anne
Publicado em 2014

Molecular and cellular pharmacology of the novel non-camptothecin topoisomerase I inhibitor, Genz-644282

por Sooryakumar, Dhriti, Dexheimer, Thomas S., Teicher, Beverly A., Pommier, Yves
Publicado em 2011

Targeting Cancer Metabolism

por Teicher, Beverly A., Linehan, W. Marston, Helman, Lee J.
Publicado em 2012

Endosialin expression in side populations in human sarcoma cell lines

por ROULEAU, CECILE, SANCHO, JOSE, CAMPOS-RIVERA, JUANITA, TEICHER, BEVERLY A.
Publicado em 2012

Analyses of the combination of 6-MP and dasatinib in cell culture

por KAUR, GURMEET, BEHRSING, HOLGER, PARCHMENT, RALPH E., MILLIN, MYRTLE DAVIS, TEICHER, BEVERLY A.
Publicado em 2013

Characteristics of human Ewing/PNET sarcoma models

por Teicher, Beverly A., Bagley, Rebecca G., Rouleau, Cecile, Kruger, Ariel, Ren, Yi, Kurtzberg, Leslie
Publicado em 2011

Association of expression of epigenetic molecular factors with DNA methylation and sensitivity to chemotherapeutic agents in cancer cell lines

por Vural, Suleyman, Palmisano, Alida, Reinhold, William C., Pommier, Yves, Teicher, Beverly A., Krushkal, Julia
Publicado no Clin Epigenetics (2021)

Bromodomain and Hedgehog Pathway Targets in Small Cell Lung Cancer

por Kaur, Gurmeet, Reinhart, Russell A., Monks, Anne, Evans, David, Morris, Joel, Polley, Eric, Teicher, Beverly A.
Publicado no Cancer Lett (2015)

Identification of pharmacodynamic biomarkers and common molecular mechanisms of response to genotoxic agents in cancer cell lines

por Min, Dong-Joon, Zhao, Yingdong, Monks, Anne, Palmisano, Alida, Hose, Curtis, Teicher, Beverly A., Doroshow, James H., Simon, Richard M.
Publicado no Cancer Chemother Pharmacol (2019)

7th Cancer Scientific Forum of the Cancéropôle Lyon Auvergne Rhône-Alpes: March 20–21, 2012, Lyon, France

por Pauwels, Petrus J., Dumontet, Charles, Reichert, Janice M., Beck, Alain, Goetsch, Liliane, Corvaïa, Nathalie, Klein, Christian, Coiffier, Bertrand, Teicher, Beverly A.
Publicado em 2012